Table: Rohto - 9-MTH group results

Rohto Pharmaceutical

12/02/2026 06:33

Feb 12 (Reuters)- 
             Rohto Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2025        Dec 31, 2024     Mar 31, 2026 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              253.07              225.90           340.50    
                   (+12.0 pct)         (+12.3 pct)      (+10.3 pct) 
  Operating           33.58               31.96            40.50    
                   (+5.1 pct)          (-9.4 pct)       (+5.9 pct)  
  Recurring           39.85               33.08            46.50    
                   (+20.5 pct)         (-11.2 pct)      (+17.1 pct) 
  Net                 28.28               24.74            33.00    
                   (+14.3 pct)         (-5.4 pct)       (+7.0 pct)  
  EPS              125.15 yen          108.46 yen       146.04 yen  
  EPS Diluted      121.12 yen          108.15 yen                   
  Ann Div                               36.00 yen        44.00 yen  
  -Q2 div           21.00 yen           16.00 yen                   
  -Q4 div                               20.00 yen        23.00 yen  
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T